Page last updated: 2024-11-05

thioridazine and Amyotrophic Lateral Sclerosis

thioridazine has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cragnaz, L1
Spinelli, G1
De Conti, L1
Bureau, EA1
Brownlees, J1
Feiguin, F1
Romano, V1
Skoko, N1
Klima, R1
Kettleborough, CA1
Baralle, FE1
Baralle, M1
Seredenina, T1
Nayernia, Z1
Sorce, S1
Maghzal, GJ1
Filippova, A1
Ling, SC1
Basset, O1
Plastre, O1
Daali, Y1
Rushing, EJ1
Giordana, MT1
Cleveland, DW1
Aguzzi, A1
Stocker, R1
Krause, KH1
Jaquet, V1

Other Studies

2 other studies available for thioridazine and Amyotrophic Lateral Sclerosis

ArticleYear
Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearance.
    Neurobiology of disease, 2021, Volume: 160

    Topics: Amyotrophic Lateral Sclerosis; Animals; Autophagy; Cell Line; Disease Models, Animal; DNA-Binding Pr

2021
Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
    Free radical biology & medicine, 2016, Volume: 97

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Female; Gene Expression

2016